Relationship Between Neurological Disability and Visual Impairment in Patients With ALS or Friedreich's Ataxia
NCT ID: NCT03285204
Last Updated: 2019-02-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
90 participants
OBSERVATIONAL
2015-07-31
2020-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Training Oculo-motor Control to Improve Vision When Using a Preferred Retinal Locus
NCT05637385
Reading Problems Associated With Central Nervous System (CNS) Pathologies.
NCT04937725
Multisensorial Analysis of Human Activity for Diagnosis and Early Detection of Functional Limitations
NCT05385328
Safety and Feasibility of the EyeControl Device
NCT02891629
Effect of Visual Retraining After Stroke
NCT06121219
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ALS patients
No interventions assigned to this group
Friedreich Ataxia patients
No interventions assigned to this group
Healthy control
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Best corrected visual acuity more than 0.4 (20/50 Snellen = 0.4 logMAR = 65 ETDRS letters).
* Refractive defect less than 5 diopters of spherical equivalent and / or cylinder less than 2 diopters.
* Transparent optical media: Opacity of crystalline \<1 according to Lens Opacities Classification System (LOCS) III.
* Open anterior chamber angle assessed by gonioscopy with Goldmann lens (grade\> III).
* Availability and collaboration to carry out the tests of the exploratory protocol.
* Acceptance of informed consent.
* Mental retardation or any other limitation in obtaining informed consent.
Exclusion Criteria
* Physical or mental difficulties to perform reliable and reproducible perimeters.
* Pathology and / or ocular malformations, angular or optic nerve anomalies.
* Any retinopathy or maculopathy.
* Intraocular pressure (IOP)\> 21 mmHg.
* Signal-to-noise ratio in OCT less than 5/10.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jose Luis Urcelay Segura
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jose Luis Urcelay Segura
Head Of ophthalmology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jose L Urcelay, PhD
Role: PRINCIPAL_INVESTIGATOR
HGU Gregorio Marañón
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pilar Rojas Lozano
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ELA-AF-OCT-2014-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.